Cyberounds Logo
September 28, 2020 | LOGIN | REGISTER | HELP | 
email a friend print Bookmark and Share
An Unusual Case of Lead Poisoning
CME credit is no longer available for this conference.
Sassan Farjami, M.D., Ogleh Nesheiwat, M.D., Carol Karmen, M.D., and Robert G. Lerner, M.D.

Drs. Farjami, Nesheiwat and Karmen are physicians in the Department of Internal Medicine at New York Medical College, Westchester Medical Center. They report no conflicts of interest. In the past three years, Dr. Lerner has been a speaker for Aventis, Novo Nordisk and Pharmacia.


Release Date: 10/04/2004
Termination Date: 10/04/2007

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine – Montefiore Medical Center designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and InterMDnet. Albert Einstein College of Medicine – Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
 
Learning Objectives
Upon completion of this Cyberounds®, you should be able to:
  • Discuss the signs, symptoms and laboratory findings of lead poisoning
  • Discuss the diagnostic evaluation of lead poisoning
  • Discuss the treatment options and the management of patients with retained bullets.

 
This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
 
Please click below to accept the terms of this CME activity